Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring perspectives from Prof John Seymour, including the following topics: Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00) Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21) First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10) CME information and select publications

Episode metadata supplied by the publisher feed · Published Sep 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

0:00 22:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 22 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on September 6, 2026.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!